Traditional Chinese medicine: Regulation a must
Earlier this year, the World Health Organization (WHO) included a chapter on traditional medicine in its International Classification of Diseases (ICD) for the first time – in what many perceived to be a boon to traditional Chinese medicine (TCM).
The ICD is an influential document. In the WHO’s own words, “ICD is increasingly used in clinical care and research to define diseases and study disease patterns, as well as manage health care, monitor outcomes and allocate resources.” Its impact spans more than 100 countries. While the WHO maintains that traditional Chinese medicine is not endorsed by its inclusion in the ICD, and that its inclusion merely represents an opportunity for “optional dual coding” (i.e. integrating traditional Chinese medicine and allopathic medicine into a treatment regimen), it was not perceived that way by many – including traditional Chinese medicine practitioners themselves.
Traditional Chinese medicine is big business in China and beyond. It is worth US$130 billion in China, home to 3,966 TCM hospitals and 45,528 TCM clinics as of 2015, as well as being a US$60 billion+ global industry spanning 180 nations.
And TCM is the main cause for the mass killing of tigers, pangolins, bears and other endangered species.
If the United Nations knows this, how on earth it is possible that the World Health Organisation (WHO) includes a chapter on TCM in its influential International Classification of Diseases (ICD).
With this the WHO is institutionalising TCM, making it even more wanted and profitable.
Ergo, making it kill even more endangered animals.